Brokerages Set Amedisys, Inc. (NASDAQ:AMED) Price Target at $100.67

Amedisys, Inc. (NASDAQ:AMED - Get Free Report) has received an average recommendation of "Hold" from the five analysts that are presently covering the stock, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $100.67.

A number of analysts have recently commented on AMED shares. Deutsche Bank Aktiengesellschaft lowered shares of Amedisys from a "buy" rating to a "hold" rating and set a $101.00 price objective on the stock. in a research report on Monday, July 29th. William Blair downgraded shares of Amedisys from an "outperform" rating to a "market perform" rating in a research note on Monday, July 1st. Finally, Cantor Fitzgerald restated a "neutral" rating and issued a $101.00 price objective on shares of Amedisys in a report on Thursday, July 25th.

Amedisys Stock Down 0.1 %

Shares of AMED traded down $0.13 during midday trading on Friday, hitting $97.22. The stock had a trading volume of 305,097 shares, compared to its average volume of 328,849. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The firm has a market cap of $3.18 billion, a price-to-earnings ratio of -151.91, a price-to-earnings-growth ratio of 1.89 and a beta of 0.78. The company has a 50 day simple moving average of $97.09 and a two-hundred day simple moving average of $95.52. Amedisys has a twelve month low of $89.55 and a twelve month high of $98.95.

Amedisys (NASDAQ:AMED - Get Free Report) last released its earnings results on Wednesday, July 24th. The health services provider reported $1.32 EPS for the quarter, beating the consensus estimate of $1.22 by $0.10. The firm had revenue of $591.19 million for the quarter, compared to analysts' expectations of $579.34 million. Amedisys had a return on equity of 12.39% and a net margin of 4.02%. On average, analysts anticipate that Amedisys will post 4.66 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of AMED. SG Americas Securities LLC boosted its stake in Amedisys by 413.4% in the 3rd quarter. SG Americas Securities LLC now owns 196,713 shares of the health services provider's stock valued at $18,985,000 after purchasing an additional 158,398 shares during the period. Highbridge Capital Management LLC boosted its position in shares of Amedisys by 34.7% in the second quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider's stock valued at $29,670,000 after acquiring an additional 83,200 shares during the period. Murchinson Ltd. bought a new position in Amedisys during the first quarter worth about $6,752,000. Calamos Advisors LLC raised its stake in Amedisys by 11.6% in the 2nd quarter. Calamos Advisors LLC now owns 397,347 shares of the health services provider's stock worth $36,476,000 after purchasing an additional 41,220 shares in the last quarter. Finally, Canada Pension Plan Investment Board raised its stake in Amedisys by 61.0% in the 2nd quarter. Canada Pension Plan Investment Board now owns 79,200 shares of the health services provider's stock worth $7,271,000 after purchasing an additional 30,000 shares in the last quarter. 94.36% of the stock is currently owned by institutional investors and hedge funds.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.